CYC.AX ASX
Cyclopharm Limited
1W: -2.2%
1M: -13.7%
3M: -4.3%
YTD: -52.7%
1Y: -53.9%
3Y: -83.4%
5Y: -82.8%
A$0.44 ($0.31)
+0.00 (+0.00%)
Weekly Expected Move ±9.6%
A$0
A$0
A$0
A$0
A$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$46M
-25.8% ▼
5Y CAGR: +10.3%
Total Liabilities
$19M
-2.1% ▼
5Y CAGR: +11.2%
Shareholders Equity
$27M
-36.6% ▼
5Y CAGR: +9.6%
Cash & Investments
$7M
-67.8% ▼
5Y CAGR: +28.7%
Total Debt
$15M
+80.1% ▲
5Y CAGR: +26.0%
Net Debt
$8M
+167.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $29M | $20M | $12M | $21M | $7M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $29M | $20M | $12M | $21M | $7M |
| Net Receivables | $8M | $8M | $8M | $8M | $9M |
| Inventory | $6M | $8M | $10M | $13M | $11M |
| Other Current Assets | $451K | $571K | $452K | $1M | $2M |
| Total Current Assets | $43M | $37M | $30M | $42M | $28M |
| Property, Plant & Equip. | $6M | $7M | $9M | $13M | $13M |
| Goodwill & Intangibles | $6M | $6M | $6M | $6M | $3M |
| Long-Term Investments | $10M | $10M | $5M | $0 | $0 |
| Other Non-Current Assets | -$11M | -$11M | -$5M | $746K | $0 |
| Total Non-Current Assets | $12M | $13M | $16M | $20M | $18M |
| Total Assets | $56M | $50M | $46M | $62M | $46M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $4M | $3M | $4M | $4M |
| Short-Term Debt | $178K | $210K | $214K | $626K | $561K |
| Deferred Revenue | $98K | $89K | $0 | $0 | $0 |
| Other Current Liabilities | -$276K | -$299K | $4M | $3M | $4M |
| Total Current Liabilities | $7M | $8M | $9M | $11M | $11M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $7M |
| Other Non-Current Liab. | $26K | $0 | $71K | $224K | -$7M |
| Total Non-Current Liabilities | $5M | $5M | $5M | $9M | $8M |
| Total Liabilities | $13M | $13M | $14M | $19M | $19M |
| — Equity — | |||||
| Common Stock | $63M | $63M | $64M | $87M | $87M |
| Retained Earnings | -$22M | -$29M | -$35M | -$48M | -$65M |
| Accumulated OCI | $2M | $2M | $3M | $4M | $5M |
| Total Stockholders Equity | $43M | $37M | $32M | $43M | $27M |
| Total Liabilities & Equity | $56M | $50M | $46M | $62M | $46M |
| — Key Metrics — | |||||
| Total Debt | $5M | $4M | $4M | $8M | $15M |
| Net Debt | -$25M | -$16M | -$7M | -$12M | $8M |
| Total Investments | $10M | $10M | $5M | $0 | $0 |